2021 Logo

The Use of Radiation Dosimetry to Optimize Radiopharmaceutical Therapy

Joseph O'Donoghue, Ph.D. | Attending Physicist, Memorial Sloan-Kettering Cancer Center

Multi-purpose in vivo Imaging in Intracranial Tumor Models to support Clinical Translation in Neuro-oncology

Anderson Clark, Ph.D. | Director of In Vivo Pharmacology, EMD Serono Research & Development Institute

Patrick McConville, Ph.D. | Vice President, Non-clinical Research Services, Invicro

Imaging Lessons from the VISION Trial

Phillip Kuo, M.D., Ph.D. | Senior Medical Director, Invicro

PET Immune Imaging in Drug Development, from Bench to Bedside Application, with Decision Making Capabilities

Kevin Maresca, Ph.D., | Senior Director and Head of PET & Molecular Imaging, Pfizer

[Roundtable] The Future of Imaging Biomarkers in Alzheimer's Disease Clinical Trials

Moderator: Roger Gunn, Ph.D. | Chief Scientific Officer, Neuroscience, Invicro

Panelists: John Beaver, Ph.D. | Vice President & Head of Biomarkers, Imaging, Bioanalytical Sciences, Translational Pathology and Diagnostic Pathways, Biogen

Susan De Santi, Ph.D. | Executive Director, Global Medical Affairs, Patient Journey, Neurology Business Group, Eisai, Inc

Gregory Klein, Ph.D. | Senior Principal Scientist & Head of Clinical Imaging, Neuroscience & Rare Disease Biomarkers & Translational Technology, Roche

Kenneth Marek, Ph.D. | Distinguished Scientist, Invicro

From Lumbar Puncture to Brain Parenchyma: Obstacles to Efficient and Repeatable Intrathecal Drug Administration

Howard Dobson, DV.Sc. | Senior Director, Discovery and Preclinical Services, Invicro

Imaging Mitochondrial-ER-Synapse Dysfunction in Neurodegeneration – The MIND MAPS Programme

Eugenii (Ilan) Rabiner, M.D. | Executive Vice President of Translational Applications, Invicro

New Outcomes, Old Measures; New Measures, Old Outcomes: Integrative Strategies for Optimizing Biomarkers in Clinical Trials of Neurodegenerative Disease

John Seibyl, M.D. | Distinguished Scientist, Invicro

Understanding the Intricacies of Fluorine-18 and Carbon-11 for Radiolabeling Success

Vince Carroll, Ph.D. | Senior Director of Chemistry, Invicro

Christophe Plisson, Ph.D. |  Head of Preclinical Services, Invicro

[Roundtable] Implementing Integrated Diagnostics: Are We Ready?

Moderator: Kenneth Bloom, M.D., FCAP | Chief Medical Officer, Advanced Pathology and Genomic Services, Invicro


Eslie Dennis, M.D., MBChB, FCP(SA) | Senior Vice President, Chief Medical Officer and Head of North America Medical Affairs, Kyowa Kirin, Inc.

Michael D. Feldman, M.D., Ph.D. | Professor, Pathology & Laboratory Medicine, Vice Chair of Clinical Services, Medical Director Pathology Informatics, Director Tumor Tissue Bank, University of Pennsylvania School of Medicine

Phillip Kuo, M.D., Ph.D. | Senior Medical Director, Invicro 

Building a Data Workbench for Analytics and AI/ML Leveraging Amazon Web Services- Managed Services

Anand Iyer | Principal Solutions Architect, Amazon Web Services

Quantitative Diagnostics in Anatomic Pathology

David Rimm, M.D., Ph.D. | Professor of Pathology and Medicine (medical oncology); Director of Pathology Tissue Services, Yale University School of Medicine

Deep Quantitative Super-resolution for Integrative Studies of Neurodegenerative Disease

Brian Avants, Ph.D. | Senior Director of Machine Learning, Invicro

iPACS® and VivoQuant™ 2021 Enhancements

Yannick Cadoret | Senior Software Engineer, Invicro

Charmaine Liang | Director of Product Management, Invicro

Jonathan Pechan | Senior Product Manager II, Invicro

Advanced Metrics and Modeling with Volumetric CT for Precision Analysis of Clinical Trial Results

Larry Schwartz, M.D. | Radiologist, Columbia Vagelos College of Physicians and Surgeons

Automated Human Phenotype Ontology Terms Matching Using a Word2Vec Model Embedding

Hamed Masnadi-Shirazi, Ph.D. | Principal Bioinformatics Scientist, Ambry Genetics